Repaglinide
Chemical compound
Repaglinide is an antidiabetic drug in the class of medications known as meglitinides, and was invented in 1983. Repaglinide is a medication used in addition to diet and exercise for blood sugar control in type 2 diabetes.
Nº Q2195995 ★
Common · Knowledge
Repaglinide
Chemical compound
Repaglinide is an antidiabetic drug in the class of medications known as meglitinides, and was invented in 1983. Repaglinide is a medication used in addition to diet and exercise for blood sugar control in type 2 diabetes.
Last price
—
Floor price
—
7-day median
—
30-day sales
0
30-day range
—
In circulation
0
Price history
median
low – high
sales
No sales in this period
Show table
| Date | median | Low | High | sales |
|---|
Sales history
- Last sale
- —
- 30-day average
- —
- 30-day low
- —
- 30-day high
- —
- Sales 7d
- 0
- Sales 30d
- 0
No sales yet.
Anonymous sales: no buyer or seller shown. Figures count player-to-player sales only.
From Wikipedia
Repaglinide is an antidiabetic drug in the class of medications known as meglitinides, and was invented in 1983. Repaglinide is a medication used in addition to diet and exercise for blood sugar control in type 2 diabetes. The mechanism of action of repaglinide involves promoting insulin release from β-islet cells of the pancreas; like other antidiabetic drugs, a main side effect concern is hypoglycemia. It is sold by Novo Nordisk under the name of Prandin in the United States, Gluconorm in Canada, Surepost in Japan, Repaglinide in Egypt, and Novonorm elsewhere. In Japan it is produced by Dainippon Sumitomo Pharma.
Text: Wikipédia, CC BY-SA 4.0. · Image: MarinaVladivostok (CC0) ·
Related cards
Liraglutide
Pharmaceutical drug
Nº Q2526479 ★★
Dulaglutide
Pharmaceutical drug
Nº Q21011228 ★★
Diabetes medication
Substances which lower blood glucose levels
Nº Q575062 ★★
Cagrilintide
Chemical compound
Nº Q123428019 ★
Nabumetone
Chemical compound
Nº Q425207 ★
Bromocriptine
Medication which has significant effects on dopamine levels in the brain
Nº Q413581 ★★